Carotid Stenting and Endarterectomy: Equal Long Term Efficacy in Symptomatic Patients

Original title: Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Reference: Bonati LH et al. Lancet. 2014;Epub ahead of print.

 

Carotid stenting is an alternative to endarterectomy though long term efficacy remains unknown. This study reports the long term follow up of the International Carotid Stenting Study.

Patients with carotid artery symptomatic lesions were randomized 1:1 to endarterectomy vs. carotid stenting in 50 centers around the world. The events were assessed by an independent committee blind to assigned treatment. Primary end point was disabling or fatal stroke in any territory from randomization to end of follow up. Functional ability was measured with the modified Rankin scale. 1,713 patients were randomized to PCI (n=855) vs endarterectomy (n=858) and followed by a median of 4.2 years. 

The total number of disabling or fatal strokes was 52 for the PCI group and 49 for the surgery group, resulting in a similar accumulative risk at 5 years for both strategies (6.4% vs 6.5%; HR 1.06, IC 95% 0.7 to 1.57; p=0.77). 

Considering any stroke, more events were observed with stenting  (119 events vs 72) with an accumulated risk at 5 years of 15.2% vs 9.4% (HR 1.71, IC 95% 1.28 to 2.30; p<0.001) but events were mostly non disabling.  Score distribution in the modified Rankin scale at one year, 5 years or end of follow up were no different in the two groups.

Conclusion

Long term functional result as well as disabling or fatal stroke risk was similar for carotid stenting and endarterectomy in patients with symptomatic carotid artery lesions.

Editorial Comment

Increased minor stroke risk associated to carotid stenting should be counterbalanced with peri procedural infarction, brain damage and endarterectomy hematoma risks. 

This study has been criticized since the start; two of the most important objections are that only 70% of PCI procedures were performed with brain protection systems, and that most operators had little experience (only 10 previous carotid stenting procedures, or a tutor, was required).

SOLACI

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...